slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
134 EUR | -0,80% | -2,05% | -4,71% |
03/07 | Johnson & Johnson's Rybrevant goedgekeurd door Health Canada voor de behandeling van gevorderde longkanker | MT |
02/07 | Momentum Picks Q3 2024: vijf aandelen voor de zomer |
Officiële publicaties
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Minutes of the general assembly | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
Dividends | CO | |
Acquisition | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO |
- Beurs
- Aandelen
- Koers JNJ
- Koers 4JNJ
- Nieuws Johnson & Johnson
- Officiële publicaties